ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07225
-0,15%
Bitcoin
65.978,61
-1,17%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aprea Therapeutics Inc (APRE)

  7. Aprea Therapeutics Inc (APRE) News

APRE

Aprea Therapeutics (APRE)

Aprea Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:APRE
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202414h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
14/05/202414h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
06/02/202423h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
05/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APREAprea Therapeutics Inc
02/02/202422h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
26/01/202413h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
26/01/202412h03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APREAprea Therapeutics Inc
04/01/202422h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
09/11/202322h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APREAprea Therapeutics Inc
09/11/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
09/11/202322h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
16/10/202323h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
13/10/202313h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
11/09/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
25/08/202303h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
25/08/202303h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
25/08/202303h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
24/08/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
10/08/202313h39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
10/08/202313h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
11/07/202313h40Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:APREAprea Therapeutics Inc
11/07/202313h30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APREAprea Therapeutics Inc
05/07/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
14/06/202314h00GlobeNewswire Inc.Aprea Therapeutics to Present at Maxim Virtual Healthcare ConferenceNASDAQ:APREAprea Therapeutics Inc
08/06/202322h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APREAprea Therapeutics Inc
30/05/202314h30GlobeNewswire Inc.Aprea Therapeutics to Present at BIO International ConventionNASDAQ:APREAprea Therapeutics Inc
15/05/202322h48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APREAprea Therapeutics Inc
15/05/202322h40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APREAprea Therapeutics Inc
15/05/202322h05GlobeNewswire Inc.Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business OperationsNASDAQ:APREAprea Therapeutics Inc
08/05/202323h16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APREAprea Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APRE

Kürzlich von Ihnen besucht

USOTC
BNPQY
BNP Paribas (QX)
PM
XAUUSD
Gold vs US Dollar
NASDAQ
MSFT
Microsoft
DBI
DAX
DAX
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
TG
MBG
MercedesBenz
TG
LHA
Deutsche Lufthansa
DBI
MDAX
MDAX
TG
DBK
Deutsche Bank
USOTC
ADDYY
Adidas (QX)
TG
D7G
Nel ASA
FX
EURJPY
Euro vs Yen
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
TG
BAS
BASF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten